跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41 条关于
“QRX009”
全部
41
临床试验
20
药物
8
机构
0
资讯
13
10天前
Quoin Pharmaceuticals Wins Second Rare Pediatric Disease Designation for Lead Skin Therapy
去年
Quoin Pharmaceuticals Appoints Sally Lawlor as CFO to Navigate QRX003 Commercialization
去年
Quoin Pharmaceuticals Initiates Pediatric Trial of QRX003 for Netherton Syndrome
去年
Quoin Pharmaceuticals Expands QRX003 Clinical Program for Netherton Syndrome and Peeling Skin Syndrome
去年
Quoin Pharmaceuticals' QRX003 Shows Promise in Netherton Syndrome Trial
11个月前
Quoin Pharmaceuticals Receives FDA Orphan Drug Designation for QRX003 in Netherton Syndrome Treatment
去年
Quoin Pharmaceuticals Advances QRX003 Clinical Programs for Rare Skin Diseases
去年
Quoin Pharmaceuticals Advances QRX003 for Rare Skin Disorders, Expands Clinical Trials
去年
Quoin Pharmaceuticals Initiates Clinical Testing of QRX003 in Pediatric Netherton Syndrome
去年
Quoin Pharmaceuticals Initiates Clinical Testing of QRX003 in Pediatric Netherton Syndrome Patient
第 1 页,共 2 页
上一页
下一页